Significance of notch1-signaling pathway in human pancreatic development and carcinogenesis

Applied Immunohistochemistry and Molecular Morphology

Volumn 21, Issue 3, 2013, Pages 242-247

  Hu, Huankai ^a   Zhou, Lan ^a,b   Awadallah, Amad ^a   Xin, Wei ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adenocarcinoma; embryogenesis; Hes1; immunohistochemistry; Notch signaling pathway; Notch1; pancreas

Indexed keywords

GAMMA SECRETASE; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1;

ACINAR CELL; ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CHILD; CHRONIC PANCREATITIS; COMPARATIVE STUDY; EMBRYO DEVELOPMENT; ENDOCRINE CELL; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MATURATION; NEWBORN; ORGANOGENESIS; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; EMBRYONIC DEVELOPMENT; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INFANT; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PREGNANCY; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION;

EID: 84876969576     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3182655ab7     Document Type: Article

References (23)

1. Heremans Y, Van De CasteeleM, in't Veld P, et al. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol. 2002;159:303-332.
2. Kopinke D, Brailsford M, Shea JE, et al. Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. Development. 2011;138:431-441.
3. Murtaugh LC, Stanger BZ, Kwan KM, et al. Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA. 2003;100:14920-14925.
4. Yevtodiyenko A, Schmidt JV. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn. 2006;235:1115-1123.
5. Apelqvist A, Li H, Sommer L, et al. Notch signalling controls pancreatic cell differentiation. Nature. 1999;400:877-881.
6. Lammert E, Brown J, Melton DA. Notch gene expression during pancreatic organogenesis. Mech Dev. 2000;94:199-203.
7. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437-450.
8. Rooman I, De Medts N, Baeyens L, et al. Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas. Am J Pathol. 2006;169:1206-1214.
9. Hanlon L, Avila JL, Demarest RM, et al. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res. 2010;70:4280-4286.
10. Jensen J, Pedersen EE, Galante P, et al. Control of endodermal endocrine development by Hes-1. Nat Genet. 2000;24:36-44.
11. Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 2003;3:565-576.
12. Wang Z, Li Y, Banerjee S, et al. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res. 2008;28:3621-3630.
13. Mysliwiec P, Boucher MJ. Targeting Notch signaling in pancreatic cancer patients-rationale for new therapy. Adv Med Sci. 2009; 54:136-142.
14. MullendoreME, Koorstra JB, LiYM, et al. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 2009;15:2291-2301.
15. Mazur PK, Einwachter H, Lee M, et al. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA. 2010;107:13438-13443.
16. Wang Z, Zhang Y, Banerjee S, et al. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer. 2006;118:1930-1936.
17. Stephen B, Edge DRB, Compton CC, et al. AJCC Cancer Staging Manual. New York: Springer; 2010:241-249.
18. Heiser PW, Hebrok M. Development and cancer: lessons learned in the pancreas. Cell Cycle. 2004;3:270-272.
19. Skandalakis LJ, Rowe JS Jr, Gray SW, et al. Surgical embryology and anatomy of the pancreas. Surg Clin North Am. 1993;73:661-697.
20. De La OJ, Emerson LL, Goodman JL, et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci USA. 2008;105:18907-18912.
21. Wang Z, Banerjee S, Li Y, et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 2006;66:2778-2784.
22. Wang Z, Zhang Y, Li Y, et al. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther. 2006;5:483-493.
23. Vizio B, Mauri FA, Prati A, et al. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma. Oncol Rep. 2012;27:69-76.